News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
562,390 Results
Type
Article (32900)
Company Profile (147)
Press Release (529342)
Multimedia
Podcasts (89)
Webinars (14)
Section
Business (167188)
Career Advice (1907)
Deals (25891)
Drug Delivery (75)
Drug Development (70858)
Employer Resources (120)
FDA (13505)
Job Trends (11501)
News (281730)
Policy (25110)
Tag
Academia (2161)
Academic (2)
Accelerated approval (4)
Adcomms (16)
Allergies (77)
Alliances (43259)
ALS (97)
Alzheimer's disease (1239)
Antibody-drug conjugate (ADC) (142)
Approvals (13549)
Artificial intelligence (277)
Autoimmune disease (27)
Automation (15)
Bankruptcy (205)
Best Places to Work (9500)
BIOSECURE Act (16)
Biosimilars (80)
Biotechnology (102)
Bladder cancer (83)
Brain cancer (32)
Breast cancer (328)
Cancer (2502)
Cardiovascular disease (171)
Career advice (1611)
Career pathing (29)
CAR-T (161)
CDC (22)
Cell therapy (455)
Cervical cancer (19)
Clinical research (58632)
Collaboration (906)
Company closure (1)
Compensation (497)
Complete response letters (14)
COVID-19 (2003)
CRISPR (50)
C-suite (265)
Cystic fibrosis (94)
Data (2658)
Decentralized trials (2)
Denatured (29)
Depression (41)
Diabetes (268)
Diagnostics (4911)
Digital health (18)
Diversity (5)
Diversity, equity & inclusion (38)
Drug discovery (124)
Drug pricing (94)
Drug shortages (23)
Duchenne muscular dystrophy (96)
Earnings (69403)
Editorial (40)
Employer branding (15)
Employer resources (108)
Events (91801)
Executive appointments (767)
FDA (14880)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (777)
Gene editing (100)
Generative AI (25)
Gene therapy (328)
GLP-1 (617)
Government (3300)
Grass and pollen (4)
Guidances (165)
Healthcare (14664)
Huntington's disease (20)
IgA nephropathy (31)
Immunology and inflammation (116)
Immuno-oncology (6)
Indications (34)
Infectious disease (2131)
Inflammatory bowel disease (137)
Inflation Reduction Act (10)
Influenza (49)
Intellectual property (100)
Interviews (363)
IPO (12732)
IRA (37)
Job creations (2433)
Job search strategy (1346)
Kidney cancer (10)
Labor market (32)
Layoffs (340)
Leadership (20)
Legal (5760)
Liver cancer (59)
Lung cancer (362)
Lymphoma (183)
Machine learning (7)
Management (39)
Manufacturing (311)
MASH (79)
Medical device (9596)
Medtech (9600)
Mergers & acquisitions (13823)
Metabolic disorders (654)
Multiple sclerosis (93)
NASH (13)
Neurodegenerative disease (96)
Neuropsychiatric disorders (22)
Neuroscience (1808)
NextGen: Class of 2025 (4822)
Non-profit (3611)
Now hiring (21)
Obesity (318)
Opinion (214)
Ovarian cancer (83)
Pain (91)
Pancreatic cancer (93)
Parkinson's disease (163)
Partnered (17)
Patents (236)
Patient recruitment (119)
Peanut (38)
People (48957)
Pharmaceutical (43)
Pharmacy benefit managers (14)
Phase I (18108)
Phase II (25729)
Phase III (19454)
Pipeline (1441)
Policy (152)
Postmarket research (2346)
Preclinical (7652)
Press Release (59)
Prostate cancer (128)
Psychedelics (22)
Radiopharmaceuticals (237)
Rare diseases (370)
Real estate (4096)
Recruiting (47)
Regulatory (17992)
Reports (32)
Research institute (2032)
Resumes & cover letters (296)
Rett syndrome (9)
RNA editing (5)
RSV (37)
Schizophrenia (72)
Series A (139)
Series B (79)
Service/supplier (6)
Sickle cell disease (46)
Special edition (15)
Spinal muscular atrophy (122)
Sponsored (24)
Startups (2693)
State (1)
Stomach cancer (10)
Supply chain (54)
Tariffs (44)
The Weekly (59)
Vaccines (621)
Venture capitalists (31)
Weight loss (187)
Women's health (31)
Worklife (14)
Date
Today (138)
Last 7 days (472)
Last 30 days (2254)
Last 365 days (28696)
2025 (13943)
2024 (30671)
2023 (34075)
2022 (43576)
2021 (46459)
2020 (43782)
2019 (37279)
2018 (27809)
2017 (26667)
2016 (25663)
2015 (29991)
2014 (24462)
2013 (20824)
2012 (21231)
2011 (21459)
2010 (20254)
Location
Africa (679)
Alabama (59)
Alaska (6)
Arizona (146)
Arkansas (11)
Asia (33620)
Australia (5250)
California (6431)
Canada (1878)
China (591)
Colorado (273)
Connecticut (294)
Delaware (176)
Europe (77069)
Florida (909)
Georgia (217)
Idaho (36)
Illinois (529)
India (26)
Indiana (303)
Iowa (16)
Japan (202)
Kansas (90)
Kentucky (23)
Louisiana (10)
Maine (35)
Maryland (856)
Massachusetts (4927)
Michigan (196)
Minnesota (316)
Mississippi (1)
Missouri (63)
Montana (23)
Nebraska (19)
Nevada (59)
New Hampshire (41)
New Jersey (1864)
New Mexico (24)
New York (1792)
North Carolina (958)
North Dakota (10)
Northern California (2869)
Ohio (207)
Oklahoma (16)
Oregon (29)
Pennsylvania (1312)
Puerto Rico (6)
Rhode Island (34)
South America (967)
South Carolina (23)
South Dakota (1)
Southern California (2439)
Tennessee (106)
Texas (930)
United States (23619)
Utah (175)
Virginia (157)
Washington D.C. (71)
Washington State (535)
West Virginia (3)
Wisconsin (68)
562,390 Results for "r and d biopharmaceuticals gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Earnings
Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp
Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist Seagen. The new cuts were revealed in the company’s Q1 earnings report.
April 29, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
PEPperPRINT GmbH launches cLIFT technology for next-generation peptide microarrays
June 10, 2025
·
3 min read
Press Releases
Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
May 23, 2025
·
7 min read
Press Releases
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Completion of Enrollment of the Global Phase 2b Study Evaluating Naronapride in Gastroparesis (MOVE-IT)
May 27, 2025
·
5 min read
Press Releases
Transpire Bio Announces R&D and Manufacturing Expansion
May 7, 2025
·
1 min read
Press Releases
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
June 16, 2025
·
1 min read
Press Releases
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
June 6, 2025
·
2 min read
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform
Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the “Sanyou Intelligent Innovative Biologics R&D Service Platform,” representing a transformative advancement in biopharmaceutical research and development.
March 12, 2024
·
2 min read
1 of 56,239
Next
